semaglutide week 4 Two-year effects of in adults with overweight or obesity: the STEP 5 trial What I Eat in a

To the extent a fund acquires shares of its Underlying ETFs in connection with creations and during reallocation, the fund typically will not acquire Underlying ETF shares on the first day of the target outcome period defined in the Underlying Funds prospectus (Target Outcome Period)

Rising awareness among healthcare professionals regarding the long-term benefits of GLP-1 receptor agonists for weight reduction and cardiovascular health is contributing to market growth

The mean BMI was 33.9 kg/m2

Vomiting rates were significantly lower compared to GLP-1 based treatments like Semaglutide and Liraglutide

As a GLP-1 receptor agonist, it helps regulate appetite, improve metabolic health, and promote overall well-being